Dr. John is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1201 16th St nw
Miami, FL 33125Phone+1 305-575-7000
Summary
- Dr. Binu John is a gastroenterologist and hepatologist in Miami, FL. He specializes in hepatology & liver transplantation, is an Affiliate Associate Professor, University of Miami Miller School of Medicine and Chief of Hepatology at the Bruce W Carters VA Medical Center. He is experienced in hepatology, transplant hepatology, portal hypertension, and hepatocellular carcinoma.
Education & Training
- Cleveland Clinic FoundationFellowship, Gastroenterology, 2007 - 2010
- Cleveland Clinic FoundationResidency, Internal Medicine, 2005 - 2007
- Christian Medical College VelloreClass of 1998
Certifications & Licensure
- FL State Medical License 2013 - 2025
- VA State Medical License 2016 - 2022
- OH State Medical License 2005 - 2018
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Publications & Presentations
PubMed
- 144 citationsFXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2.Teresa Brevini, Mailis Maes, Gwilym J Webb, Binu V John, Claudia D Fuchs
Nature. 2023-03-01 - 385 citationsFecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trialJasmohan S. Bajaj, Zain Kassam, Andrew Fagan, Edith Gavis, Eric J. Liu
Hepatology. 2017-12-01 - 43 citationsSpecific Gut and Salivary Microbiota Patterns Are Linked With Different Cognitive Testing Strategies in Minimal Hepatic Encephalopathy.Jasmohan S. Bajaj, Andrew Fagan, Melanie B. White, James B. Wade, Phillip B. Hylemon
The American Journal of Gastroenterology. 2019-01-01
Press Mentions
- Third COVID-19 Vaccine Dose Reduces Infection, Critical Disease Risk in Cirrhosis by 80%November 7th, 2022
- Third Dose of COVID-19 Vaccine Offers Needed Boost in Protection for Cirrhosis PatientsOctober 26th, 2022
- Miller School Faculty Front and Center at DDW ’22June 28th, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: